0000950170-24-019457.txt : 20240223 0000950170-24-019457.hdr.sgml : 20240223 20240223170008 ACCESSION NUMBER: 0000950170-24-019457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240222 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUMER JACQUELYN L CENTRAL INDEX KEY: 0001844824 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39856 FILM NUMBER: 24672317 MAIL ADDRESS: STREET 1: C/O GENOCEA BIOSCIENCES, INC. STREET 2: 100 ACORN PARK DRIVE 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cullinan Oncology, Inc. CENTRAL INDEX KEY: 0001789972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813867811 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 1350 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-410-4650 MAIL ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 1350 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Cullinan Management, Inc. DATE OF NAME CHANGE: 20210107 FORMER COMPANY: FORMER CONFORMED NAME: Cullinan Oncology, LLC DATE OF NAME CHANGE: 20191001 4 1 ownership.xml 4 X0508 4 2024-02-22 0001789972 Cullinan Oncology, Inc. CGEM 0001844824 SUMER JACQUELYN L C/O CULLINAN ONCOLOGY, INC. ONE MAIN STREET, SUITE 1350 CAMBRIDGE MA 02142 false true false false Chief Legal Officer false Common Stock 2024-02-22 4 A false 50000 0.00 A 94133 D Stock Option (Right to Buy) 17.54 2024-02-22 4 A false 100000 0.00 A 2034-02-22 Common Stock 100000 100000 D The shares underlying the restricted stock unit vest on an annual basis over four years. The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. /s/ Jacquelyn Sumer 2024-02-23